Recommendations for preventing fracture in long-term care

CMAJ

Volumn 187, Issue 15, 2015, Pages 1135-1144

  Papaioannou, Alexandra ^a,b   Santesso, Nancy ^a   Morin, Suzanne N ^c,d   Feldman, Sidney ^e,g   Adachi, Jonathan D ^a,h   Crilly, Richard ⁱ   Giangregorio, Lora M ^j   Jaglal, Susan ^f,k   Josse, Robert G ^e,l   Kaasalainen, Sharon ^a   Katz, Paul ^g   Moser, Andrea ^e,g   Pickard, Laura ^a,b   Weiler, Hope ^m   Whiting, Susan ⁿ   Skidmore, Carly J ^b   Cheung, Angela M ^e,o  

^a MCMASTER UNIVERSITY   (Canada)

^b St Peter's Hospital   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d MONTREAL GENERAL HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g BAYCREST CENTRE FOR GERIATRIC CARE   (Canada)

^h MCMASTER UNIVERSITY   (Canada)

ⁱ UNIVERSITY OF WESTERN ONTARIO   (Canada)

^j UNIVERSITY OF WATERLOO   (Canada)

^k INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^l ST MICHAEL'S HOSPITAL   (Canada)

^m MCGILL UNIVERSITY   (Canada)

ⁿ UNIVERSITY OF SASKATCHEWAN   (Canada)

^o TORONTO GENERAL HOSPITAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CALCIUM CARBONATE; CITRATE CALCIUM; COLECALCIFEROL; DENOSUMAB; ERGOCALCIFEROL; ETIDRONIC ACID; PARATHYROID HORMONE[1-34]; RALOXIFENE; RISEDRONIC ACID; VITAMIN D; ZOLEDRONIC ACID;

CALCIUM INTAKE; CANADA; DIET SUPPLEMENTATION; DRUG COST; EXERCISE; FRACTURE; FRAIL ELDERLY; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HIGH RISK POPULATION; HIP FRACTURE; HIP PROTECTOR; HUMAN; HYPERCALCEMIA; INTERDISCIPLINARY COMMUNICATION; KIDNEY FAILURE; LONG TERM CARE; NEPHROLITHIASIS; OSTEOPOROSIS; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIMARY PREVENTION; PROTECTIVE EQUIPMENT; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; SPINE FRACTURE; SYSTEMATIC REVIEW; VITAMIN INTAKE; ADULT; COMPLICATION; FRACTURES, BONE; MIDDLE AGED; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ADULT; CANADA; FRACTURES, BONE; HUMANS; LONG-TERM CARE; MIDDLE AGED; OSTEOPOROSIS; RISK FACTORS;

EID: 84945573179     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.141331     Document Type: Article

References (68)

1. Papaioannou A, Morin S, Cheuxong AM, et al. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 2010;182:1864-73.
2. Crilly RG, Tanner DA, Kloseck M, et al. Hip fractures in longterm care: Is the excess explained by the age and gender distribution of the residents? J Aging Res 2010;2010:291258.
3. Ronald LA, McGregor MJ, McGrail KM, et al. Hospitalization rates of nursing home residents and community-dwelling seniors in British Columbia. Can J Aging 2008;27:109-15.
4. Zimmerman S, Chandler JM, Hawkes W, et al. Effect of fracture on the health care use of nursing home residents. Arch Intern Med 2002;162:1502-8.
5. Nikitovic M, Wodchis WP, Krahn MD, et al. Direct health-care costs attributed to hip fractures among seniors: a matched cohort study. Osteoporos Int 2013;24:659-69.
6. Rodondi, A, Chevalley T, Rizzoli R. Prevalence of vertebral fracture on oldest old nursing home residents. Osteoporosis Int 2012;23:2601-6.
7. Papaioannou A, Watts NB, Kendler DL, et al. Diagnosis and management of vertebral fractures in elderly adults. Am J Med 2002;113:220-8.
8. Caring for seniors with Alzheimer's disease and other forms of dementia. Ottawa: Canadian Institute of Health Information; 2010. Available: https://secure.cihi.ca/free-products/Dementia- AIB-2010-EN.pdf (accessed 2013 May 15).
9. Easterling CS, Robbins E. Dementia and dysphagia. Geriatr Nurs 2008;29:275-85.
10. Jackson LD, Little J, Kung E, et al. Safe medication swallowing in dysphagia: a collaborative improvement project. Healthc Q 2008;11(3 Spec No.):110-6.
11. Papaioannou A, Ray JG, Ferko NC, et al. Estimation of creati-nine clearance in elderly persons in long-term care facilities. Am J Med 2001;111:569-73.
12. Garg AX, Papaioannou A, Ferko N, et al. Estimating the prevalence of renal insuffciency in seniors requiring long-term care. Kidney Int 2004;65:649-53.
13. Leslie WD, Berger C, Langsetmo L, et al.; Canadian Multicentre Osteoporosis Study Research Group. Construction and validation of a simplifed fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts. Osteoporos Int 2011;22:1873-83.
14. Bravo G, Dubois MF, De Wals P, et al. Relationship between regulatory status, quality of care, and three-year mortality in Canadian residential care facilities: a longitudinal study. Health Serv Res 2002;37:1181-96.
15. Reid CR. Quality of care and mortality among long-term care residents with dementia. Can Stud Popul 2008;35:49-71.
16. Cox L, Kloseck M, Crilly R, et al. Underrepresentation of individuals 80 years of age and older in chronic disease clinical practice guidelines. Can Fam Physician 2011;57:e263-9.
17. Mutasingwa DR, Ge H, Upshur RE. How applicable are clinical practice guidelines to elderly patients with comorbidities? Can Fam Physician 2011;57:e253-62.
18. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6.
19. Guyatt GH, Oxman AD, Kunz R, et al.; GRADE Working Group. Going from evidence to recommendations. BMJ 2008;336:1049-51.
20. Kanis JA, Johnell O, Oden A, et al. The risk and burden of vertebral fractures in Sweden. Osteoporos Int 2004;15:20-6.
21. Chandler JM, Zimmerman SI, Girman CJ, et al. Low bone mineral density and risk of fracture in white female nursing home residents. JAMA 2000;284:972-7.
22. Leslie WD, Sadatsafavi M, Lix LM, et al. Secular decreases in fracture rates 1986-2006 for Manitoba, Canada: a population-based analysis. Osteoporos Int 2011;22:2137-43.
23. Lindsay R, Silverman SL, Cooper C, et al. Risk of new vertebral fracture in the year following a fracture. JAMA 2001;285:320-3.
24. Bischoff-Ferrari HA, Willett WC, Orav EJ, et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med 2012;367:40-9.
25. Autier P, Gandini S, Mullie P. A systematic review: infuence of vitamin D supplementation on serum 25-hydroxyvitamin D concentration. J Clin Endocrinol Metab 2012;97:2606-13.
26. Avenell A, Gillespie WJ, Gillespie LD, et al. Vitamin D and vitamin D analogues for preventing fractures associated with involu-tional and post-menopausal osteoporosis. Cochrane Database Syst Rev 2009;(2):CD000227.
27. Murad MH, Drake MT, Mullan RJ, et al. Clinical review. Comparative effectiveness of drug treatments to prevent fragility fractures: a systematic review and network meta-analysis. J Clin Endocrinol Metab 2012;97:1871-80.
28. Grant AM, Avenell A, Campbell MK, et al.; RECORD Trial Group. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 2005;365:1621-8.
29. Muir SW, Montero-Odasso M. Effect of vitamin D supplementation on muscle strength, gait and balance in older adults: a systematic review and meta-analysis. J Am Geriatr Soc 2011;59:2291-300.
30. Murad MH, Elamin KB, Abu Elnour NO, et al. Clinical review: the effect of vitamin D on falls: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011;96:2997-3006.
31. Cameron ID, Gillespie LD, Robertson MC, et al. Interventions for preventing falls in older people in care facilities and hospitals. Cochrane Database Syst Rev 2012;12:CD005465.
32. Gillespie LD, Robertson MC, Gillespie WJ, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2012;9:CD007146.
33. Reid IR, Mason B, Horne A, et al. Randomized controlled trial of calcium in healthy older women. Am J Med 2006;119:777-85.
34. Nurmi I, Lüthje P. Incidence and costs of falls and fall injuries among elderly in institutional care. Scand J Prim Health Care 2002;20:118-22.
35. Elamin MB, Abu Elnour NO, Elamin KB, et al. Vitamin D and cardiovascular outcomes: a systematic review and meta-analy-sis. J Clin Endocrinol Metab 2011;96:1931-42.
36. Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 2010;341:c3691.
37. Bolland MJ, Grey A, Avenell A, et al. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ 2011;342:d2040.
38. Levis S, Theodore G. Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report. J Manag Care Pharm 2012;18(4 Suppl B):S1-15.
39. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med 2009;169:551-61.
40. Fosamax alendronate sodium tablets [product monograph]. Kirkland (QC): Merck Canada Inc.; revised 2015 Aug. 4. Available: www.merck.ca/assets/en/pdf/products/FOSAMAX-PM-E. pdf (accessed 2015 Aug. 23).
41. Actonel risedronate sodium [product monograph]. Toronto: Warner Chilcott Canada Co.; revised 2011 July 15. Available: www.sanof.ca/products/en/actonel.pdf (accessed 2015 Aug. 23).
42. Aclasta (zoledronic acid injection) [product monograph]. Dorval (QC): Novartis Pharmaceuticals Canada Inc.; 2005 June 30, revised 2014 Sep. 11. Available: www.novartis.ca/en/products/pharmaceuticals/index.shtml (accessed 2015 Aug. 23).
43. Updated renal safety information on Zometa (zoledronic acd) and Aclasta (zoledronic acid)-Novartis Pharmaceuticals Canada Inc.-for health professionals. Ottawa: Health Canada. Available: http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2005/14383a-eng.php (accessed 2015 Aug. 23).
44. Prolia (denosumab) [product monograph]. Mississauga (ON): Amgen Canada Inc.; 2014 Oct. 20. Available: https://www.amgen.ca/Prolia-PM.pdf (accessed 2015 Aug. 23).
45. Hopkins RB, Goeree R, Pullenayegum E, et al. The relative effcacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women. BMC Musculoskelet Disord 2011;12:209.
46. Bolland MJ, Grey AB, Gamble GD, et al. Effect of osteoporosis treatment on mortality: a meta-analysis. J Clin Endocrinol Metab 2010;95:1174-81.
47. Nevitt MC, Chen P, Dore RK, et al. Reduced risk of back pain following teriparatide treatment: a meta-analysis. Osteoporos Int 2006;17:273-80.
48. Hadji P, Ziller V, Gamerdinger D, et al. Quality of life and health status with zoledronic acid and generic alendronate - a secondary analysis of the Rapid Onset and Sustained Effcacy (ROSE) study in postmenopausal women with low bone mass. Osteoporos Int 2012;23:2043-51.
49. Sambrook PN, Silverman SL, Cauley JA, et al. Health-related quality of life and treatment of postmenopausal osteoporosis: results from the HORIZON-PFT. Bone 2011;48:1298-304.
50. Jacobsen DE, Melis RJ, Verhaar HJ, et al. Raloxifene and tibolone in elderly women: a randomized, double-blind, double-dummy, placebo-controlled trial. J Am Med Dir Assoc 2012;13:e1-7.
51. Silverman S, Viswanathan HN, Yang YC, et al. Impact of clinical fractures on health-related quality of life is dependent on time of assessment since fracture: results from the FREEDOM trial. Osteoporos Int 2012;23:1361-9.
52. Rizzoli R, Burlet N, Cahall D, et al. Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis. Bone 2008;42:841-7.
53. Rizzoli R, Reginster JY, Boonen S, et al. Adverse reactions and drug-drug interactions in the management of women with post-menopausal osteoporosis. Calcif Tissue Int 2011;89:91-104.
54. Rizzoli R, Åkesson K, Bouxsein M, et al. Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation working group report. Osteoporos Int 2011;22:373-90.
55. Mak A, Cheung MW, Ho RC, et al. Bisphosphonates and atrial fbrillation: Bayesian meta-analyses of randomized controlled trials and observational studies. BMC Musculoskelet Disord 2009;10:113.
56. Grady D, Cauley JA, Stock JL, et al. Effect of raloxifene on all-cause mortality. Am J Med 2010;123:e1-7.
57. Toulis KA, Anastasilakis AD. Increased risk of serious infections in women with osteopenia or osteoporosis treated with denosumab. Osteoporos Int 2010;21:1963-4.
58. Santesso N, Carrasco-Labra A, Brignardello-Petersen R. Hip protectors for preventing hip fractures in older people. Cochrane Database Syst Rev 2014;3:CD001255.
59. American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. New York: American Geriatrics Society; 2012. Available: http://geriatricscare online.org/ProductAbstract/american-geriatrics-society-updated-beers-criteria-for-potentially-inappropriate-medication-use-in-older-adults/CL001 (accessed 2015 Aug. 20).
60. American Geriatrics Society Expert Panel on the Care of Older Adults with Multimorbidity. Guiding principles for the care of older adults with multimorbidity: an approach for clinicians. J Am Geriatr Soc 2012;60:E1-25.
61. Duque G, Close JJ, deJager JP, et al. Treatment for osteoporosis in Australian residential age care facilities. Med J Aust 2010;193:173-9.
62. Osteoporosis and fracture prevention in the long-term care setting: clinical practice guideline. Columbia (MD): American Medical Directors Association; 2009.
63. American Geriatrics Society Workgroup on Vitamin D. Supplementation for older adults. Recommendations abstracted from the American Geriatrics Society consensus statement on vitamin D for prevention of falls and their consequences. J Am Geriatr Soc 2014;62:147-52.
64. Rosen CJ, Abrams SA, Aloia JF, et al. IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab 2012;97:1146-52.
65. Hanley DA, Cranney A, Jones G, et al. Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada. CMAJ 2010;182:E610-8.
66. Girman CJ, Chandler JM, Zimmerman SI, et al. Prediction of fracture in nursing home residents. J Am Geriatr Soc 2002;50:1341-7.
67. Colón-Emeric CS, Biggs DP, Schenck AP, et al. Risk factors for hip fracture in skilled nursing facilities: Who should be evaluated? Osteoporos Int 2003;14:484-9.
68. Chen JS, Sambrook PN, Simpson JM, et al. A selection strategy was developed for fracture reduction programs in frail older people. J Clin Epidemiol 2010;63:679-85.